Pros
Tremendous financial upside IF it penetrates just a few major market players.
Great collaborative culture where politics are set aside.
Highly popular with outside wannabe employees since they know the culture will be good.
Potential to actually affect 21st century medicine by restoring secure, confidential partnerships between main stream partners and the Bio-Pharma industry.
Cons
Early phase startups require a lot of time networking for the next round of funding if needed.